Eurofins PhenoBiome Inks US Distribution Deal With Genetic Direction for Gut Microbiome Assay Service The assay assesses an individual's gut microbiome to provide a report that can guide behavioral and other health interventions to improve gut health. NY State Department of Health Approves Eurofins Viracor Transplant Rejection Tests The Viracor TRAC donor-derived cell-free DNA test and TruGraf blood gene expression test both assess rejection status in kidney transplant recipients. As SARS-CoV-2 Variants Complicate Efforts to Tame Pandemic, Eurofins Test Helps to ID Mutations Premium Eurofins said its new multiplex PCR kit could be impactful for countries looking to gain control of disease clusters triggered by SARS-CoV-2 variants. Eurofins Scientific Posts 17 Percent Increase in FY2020 Revenues The company also said that it had received EUA from the US Food and Drug Administration for a non-prescription version of its COVID-19 sample collection kit. Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test The test, which was developed by researchers at the Cleveland Clinic and the University of Alabama, looks for RNA molecules in urine that indicate rejection. Jan 8, 2021 New Products Posted to GenomeWeb: Diagenode, Analytical BioSciences, Eurofins Genomics Dec 15, 2020 Eurofins Increases 2020 Revenue Guidance to €5.3B Oct 22, 2020 Eurofins Q3 Revenues Rise 17 Percent on COVID-19 Testing Oct 19, 2020 Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs Jul 20, 2020 Boston Heart Diagnostics Coronavirus Test Gets FDA Emergency Use Authorization May 7, 2020 Eurofins Technologies Gets CE-IVD Mark for Multiplex Coronavirus Test May 1, 2020 People in the News: Peter Meintjes, Timothy Chan, Satnam Alag, More Apr 17, 2020 New Products Posted to GenomeWeb: Illumina, Eurofins Genomics, Loop Genomics, More Apr 7, 2020 FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT Mar 17, 2020 Viracor Eurofins, National Kidney Registry Partner to Provide SARS-CoV-2 Testing Dec 10, 2019 Eurofins Scientific, Medicinal Genomics Partner on Cannabis SNP Chip Oct 7, 2019 Eurofins GeneScan Technologies to Deploy Assays on UgenTec PCR Analysis Platform Sep 26, 2019 CareDx Sues Eurofins Viracor for Patent Infringement Aug 6, 2019 Eurofins Genomics Buys Gene Synthesis Firm Blue Heron Jun 25, 2019 Eurofins Acquires Transplant Genomics May 7, 2019 Adial Pharmaceuticals, Eurofins Scientific Partner on CDx for Alcohol Use Disorder Drug Mar 28, 2019 Eurofins Subsidiary Gets New York State Approval for Addition of Y Chromosome Screen to NIPT Test Nov 20, 2018 Eurofins, Synthego Sign Distribution Agreement for Synthetic Single-Guide RNA Products Feb 16, 2018 SenzaGen Inks Global Distribution Deal for Skin Allergy Test Oct 30, 2017 Toyota Licenses Rapid DNA Analysis Tech to Kazusa, Eurofins, GeneBay Load More Breaking News People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More FDA Grants Emergency Use Authorization for Northeastern University SARS-CoV-2 Test FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.